Our Experts

Physician Profile

Paul Szabolcs, MD

Paul Szabolcs, MD
Job Title Chief, Division of Blood and Marrow Transplantation and Cellular Therapies
Job Title Professor, Pediatrics, University of Pittsburgh School of Medicine
4401 Penn Avenue, Suite Floor 9
Pittsburgh, PA 15224
Contact Information:
412-692-6752 Fax

Education and Training

Medical School:

1985 Semmelweis University School of Medicine, Budapest, Hungary 


1990 Pediatric residency, Bellevue Hospital, New York University School of Medicine


1993 Hematology/Oncology/Bone Marrow Transplantation fellowship, Memorial Sloan-Kettering Cancer Center (MSKCC)/Cornell University Medical College

Academic Appointments:

1994-1998 Instructor in Pediatrics, MSKCC

1993-1997 Guest Investigator, Research Associate, The Rockefeller University

1998-2006 Assistant Professor of Pediatrics, Duke University School of Medicine

2006-2011 Associate Professor of Pediatrics, Duke University School of Medicine


  • American Society of Hematology
  • American Society for Blood & Marrow Transplantation
  • American Association of Immunologists
  • American Academy of Pediatrics
  • Center for International Blood and Transplant Research (CIBMTR): Immune Deficiencies/Inborn Errors Working Committee
  • CIBMTR: Graft-vs-Host Disease Working Committee
  • International Society for Cellular Therapy (ISCT): Immunotherapy and Dendritic Cell Committee
  • Society for Pediatric Research (SPR) Member
  • Co-Chair, CIBMTR: Infection and Immune Reconstitution Working Committee
  • Clinical Immunology Society

Board Certifications

  • American Board of Pediatrics
  • Pediatric Hematology-Oncology, Sub-Board of American Board of Pediatrics


  • 1980 First Prize for Critical Thesis, Human globin genes, Pecs University of Medical Sciences, Pecs, Hungary
  • 1980 Elected "Best Student of the Year," Pecs University of Medical Sciences, Pecs, Hungary
  • 2000 Lisa Stafford Memorial Research Prize, Duke University Comprehensive Cancer Center, Durham, N.C.

Research Interests

  • understanding the biology of immune reconstitution, tolerance,  and alloreactivity after cord blood and bone marrow transplantation
  • developing immunotherapy strategies to prevent or treat leukemia relapse after cord blood transplantation

Clinical Specialties

  • development of novel reduced toxicity transplant conditioning regimens to improve the safety of cord blood transplantation for children with nonmalignant diseases or with advanced leukemias
  • combining unrelated donor bone marrow transplantation with lung transplantation for curative treatment of rare immune  and other inherited disorders resulting in pulmonary failure 

Active Research Projects / Grants

  • Immune Monitoring Core Laboratory for BMT CTN 05-01 Trial
  • Graft Engineering and Immunotherapy After Unrelated Cord Blood Transplantation
  • Ancillary Studies in Clinical Trials: Immune Reconstitution After Cord Blood Transplantation
Last Update
November 8, 2012
  • Increase/Decrease Text Size
  • Print This Page
Last Update
November 8, 2012